RECRUITINGNA

Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)

This is a a type 3 hybrid effectiveness-implementation pilot study to evaluate the PRONTO-EYE intervention, a rideshare transportation program, in patients with diabetic retinopathy with Medicaid insurance on adherence to ophthalmology visits.

Sponsor

University of Illinois at Chicago

Enrollment

60 participants

Sites

1 locations

Start Date

February 2026

Completion

June 2026

Diabetic Retinopathy (DR)PRONTO-EYE

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

16 months

total trial span

Rate

pts/month needed

Feb 2026Month 5 of 16Jun 2026

31% of trial timeline elapsed11 months to primary endpoint

At 1 sites, each site needs to enroll approximately 4.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Number of patients that adhere to their scheduled ophthalmology visits

Baseline up to 6 months

Proportion of patients who attend their scheduled ophthalmology visit compared to pre-implementation historical controls.

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

RECRUITINGNA

Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)

Sponsor

University of Illinois at Chicago

Enrollment

60 participants

Sites

1 locations

Start Date

February 2026

Completion

June 2026

Diabetic Retinopathy (DR)PRONTO-EYE

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

16 months

total trial span

Rate

pts/month needed

Feb 2026Month 5 of 16Jun 2026

31% of trial timeline elapsed11 months to primary endpoint

At 1 sites, each site needs to enroll approximately 4.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Number of patients that adhere to their scheduled ophthalmology visits

Baseline up to 6 months

Proportion of patients who attend their scheduled ophthalmology visit compared to pre-implementation historical controls.

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)